keyword
https://read.qxmd.com/read/38647885/involved-field-radiotherapy-in-older-patients-with-superficial-thoracic-esophageal-squamous-cell-carcinoma-long-term-outcomes-and-recurrence-patterns
#1
JOURNAL ARTICLE
Sawa Kono, Yaichiro Hashimoto, Kenta Ohmatsu, Miki Tsujii, Shigehiko Kuribayashi, Kumiko Karasawa
PURPOSE: An optimal radiotherapy field for superficial esophageal carcinoma is yet to be established. We evaluated the long-term outcomes and recurrence patterns of involved-field radiotherapy (IFRT) in older patients with superficial thoracic esophageal squamous cell carcinoma (ESCC). MATERIALS AND METHODS: Fifty-four patients (49 men and 5 women; mean age, 77 [range: 66-90] years) who underwent IFRT for superficial thoracic ESCC between January 2003 and January 2019 were retrospectively reviewed...
April 22, 2024: Japanese Journal of Radiology
https://read.qxmd.com/read/38646643/exploring-the-role-of-combined-external-beam-radiotherapy-and-targeted-radioligand-therapy-with-177-lu-lu-psma-617-for-prostate-cancer-from-bench-to-bedside
#2
JOURNAL ARTICLE
Daria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, Lisa-Charlotte Domogalla, Nils Steinacker, Michael Mix, Gabriele Niedermann, Simon K B Spohn, Martin T Freitag, Anca L Grosu, Philipp T Meyer, Christian Gratzke, Matthias Eder, Constantinos Zamboglou, Ann-Christin Eder
Management of prostate cancer (PC) might be improved by combining external beam radiotherapy (EBRT) and prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) with lutetium-177 (177 Lu)-labeled PSMA inhibitors. We hypothesized a higher efficacy of the combination due to augmentation of the radiation dose to the tumor and interactions of EBRT with PSMA expression potentially increasing radiopharmaceutical uptake. Therefore, this study analyzed the influence of radiation on PSMA expression levels in vitro ...
2024: Theranostics
https://read.qxmd.com/read/38642199/primary-management-of-operable-locally-advanced-oral-cavity-squamous-cell-carcinoma-current-concepts-and-strategies
#3
REVIEW
Ameya A Asarkar, Brent A Chang, Remco de Bree, Luiz P Kowalski, Orlando Guntinas-Lichius, Patrick J Bradley, Pim de Graaf, Primož Strojan, Karthik N Rao, Antti A Mäkitie, Fernando López, Alessandra Rinaldo, Carsten Palme, Eric M Genden, Alvaro Sanabria, Juan P Rodrigo, Alfio Ferlito
INTRODUCTION: Locally advanced oral cavity carcinoma (LAOCSCC) is primarily treated with surgery followed by radiotherapy with or without chemotherapy. METHODS: A review of literature using PubMED was performed for studies reporting the management of LAOCSCC. Based on the reviewed literature and opinions of experts in the field, recommendations were made. RESULTS: Studies have shown that outcomes following resection of T4a and infranotch (inferior to mandibular notch) T4b are comparable...
April 20, 2024: Advances in Therapy
https://read.qxmd.com/read/38640786/aurora-kinase-a-inhibition-plus-tumor-treating-fields-suppress-glioma-cell-proliferation-in-a-cilium-independent-manner
#4
JOURNAL ARTICLE
Jia Tian, Julianne C Mallinger, Ping Shi, Dahao Ling, Loic P Deleyrolle, Min Lin, Habibeh Khoshbouei, Matthew R Sarkisian
Tumor Treating Fields (TTFields) extend the survival of glioblastoma (GBM) patients by interfering with a broad range of tumor cellular processes. Among these, TTFields disrupt primary cilia stability on GBM cells. Here we asked if concomitant treatment of TTFields with other agents that interfere with GBM ciliogenesis further suppress GBM cell proliferation in vitro. Aurora kinase A (AURKA) promotes both cilia disassembly and GBM growth. Inhibitors of AURKA, such as Alisertib, inhibit cilia disassembly and increase ciliary frequency in various cell types...
April 18, 2024: Translational Oncology
https://read.qxmd.com/read/38639669/synthetic-biology-approaches-for-enhancing-safety-and-specificity-of-car-t-cell-therapies-for-solid-cancers
#5
JOURNAL ARTICLE
Grace C Russell, Yassin Hamzaoui, Daniel Rho, Gaurav Sutrave, Joseph S Choi, Dara S Missan, Gabrielle A Reckard, Michael P Gustafson, Gloria B Kim
CAR-T cell therapies have been successful in treating numerous hematologic malignancies as the T cell can be engineered to target a specific antigen associated with the disease. However, translating CAR-T cell therapies for solid cancers is proving more challenging due to the lack of truly tumor-associated antigens and the high risk of off-target toxicities. To combat this, numerous synthetic biology mechanisms are being incorporated to create safer and more specific CAR-T cells that can be spatiotemporally controlled with increased precision...
March 30, 2024: Cytotherapy
https://read.qxmd.com/read/38635829/geraniol-and-citral-recent-developments-in-their-anticancer-credentials-opening-new-vistas-in-complementary-cancer-therapy
#6
REVIEW
Gauri Srivastava, Esha Mukherjee, Ruchika Mittal, Deepak Ganjewala
About 10 million people are diagnosed with cancer each year. Globally, it is the second leading cause of death after heart disease, and by 2035, the death toll could reach 14.6 million. Several drugs and treatments are available to treat cancer, but survival rates remain low. Many studies in recent years have shown that plant-derived monoterpenes, particularly geraniol and citral, are effective against various cancers, including breast, liver, melanoma, endometrial, colon, prostate, and skin cancers. This trend has opened new possibilities for the development of new therapeutics or adjuvants in the field of cancer therapy...
April 19, 2024: Zeitschrift Für Naturforschung. C, A Journal of Biosciences
https://read.qxmd.com/read/38629283/skin-cancer-occurrence-single-center-experiences-from-period-2020-2022
#7
JOURNAL ARTICLE
Łukasz Łaziński, Mateusz Koziej, Bogusław Antoszewski, Marta Fijałkowska
<b><br>Introduction:</b> Skin cancers constitute a group of medical disorders remaining a field of interest for surgeons and dermatologists. Currently, this group is typically divided into malignant melanoma (MM) and keratinocyte cancers (KC).</br> <b><br>Aim:</b> The aim of this study is to analyze the cases of skin cancers treated in the Department of Plastic, Reconstructive, and Aesthetic Surgery in Lodz (Poland) during the COVID-19 pandemic (from 2020 to 2022) and then compare the results with the ones from the pre-pandemic period (from 2017 to 2019)...
October 12, 2023: Polski Przeglad Chirurgiczny
https://read.qxmd.com/read/38627421/exploring-fetal-brain-tumor-glioblastoma-symptom-verification-with-self-organizing-maps-and-vulnerability-data-analysis
#8
JOURNAL ARTICLE
Suresh Kumar Natarajan, Jayanthi S, Sandeep Kumar Mathivanan, Hariharan Rajadurai, Benjula Anbu M B, Mohd Asif Shah
Brain tumor glioblastoma is a disease that is caused for a child who has abnormal cells in the brain, which is found using MRI "Magnetic Resonance Imaging" brain image using a powerful magnetic field, radio waves, and a computer to produce detailed images of the body's internal structures it is a standard diagnostic tool for a wide range of medical conditions, from detecting brain and spinal cord injuries to identifying tumors and also in evaluating joint problems. This is treatable, and by enabling the factor for happening, the factor for dissolving the dead tissues...
April 16, 2024: Scientific Reports
https://read.qxmd.com/read/38623975/early-detection-precision-treatment-recurrence-monitoring-liquid-biopsy-transforms-colorectal-cancer-therapy
#9
JOURNAL ARTICLE
Harshvardhan Raval, Sankha Bhattacharya
Colorectal cancer (CRC) is a significant global health concern. We need ways to detect it early and determine the best treatments. One promising method is liquid biopsy, which uses cancer cells and other components in the blood to help diagnose and treat the disease. Liquid biopsies focus on three key elements: circulating tumor DNA (ctDNA), circulating microRNA (miRNA), and circulating tumor cells (CTC). By analyzing these elements, we can identify CRC in its early stages, predict how well a treatment will work, and even spot signs of cancer returning...
April 15, 2024: Current Cancer Drug Targets
https://read.qxmd.com/read/38617971/a-bibliometric-analysis-of-the-research-landscape-on-vascular-normalization-in-cancer
#10
JOURNAL ARTICLE
Hanghang Xie, Shan Wang, Dongling Niu, Chao Yang, Hongmei Bai, Ting Lei, Hongli Liu
Tumor vascular normalization profoundly affects the advancement of cancer therapy. Currently, with the rapid increase in research on tumor vascular normalization, few analytical and descriptive studies have investigated the trends in its development, key research power, present research hotspots, and future outlooks. In this study, articles and reviews published between January 1, 2003, and October 29, 2022 were retrieved from Web of Science database. Subsequently, published research trends, countries/regions, institutions, authors, journals, references, and keywords were analyzed based on traditional bibliometric laws (such as Price's exponential growth, Bradford's, Lotka's, and Zipf's)...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38617252/rapid-differentiation-of-estrogen-receptor-status-in-patient-biopsy-breast-cancer-aspirates-with-an-optical-nanosensor
#11
Pooja V Gaikwad, Nazifa Rahman, Pratyusha Ghosh, Dianna Ng, Ryan M Williams
Breast cancer is a substantial source of morbidity and mortality worldwide. It is particularly more difficult to treat at later stages, and treatment regimens depend heavily on both staging and the molecular subtype of the tumor. However, both detection and molecular analyses rely on standard imaging and histological method, which are costly, time-consuming, and lack necessary sensitivity/specificity. The estrogen receptor (ER) is, along with the progesterone receptor (PR) and human epidermal growth factor (HER-2), among the primary molecular markers which inform treatment...
April 1, 2024: bioRxiv
https://read.qxmd.com/read/38613216/dawn-of-car-t-cell-therapy-in-autoimmune-diseases
#12
JOURNAL ARTICLE
Yuxin Liu, Minghao Dong, Yunhui Chu, Luoqi Zhou, Yunfan You, Xiaowei Pang, Sheng Yang, Luyang Zhang, Lian Chen, Lifang Zhu, Jun Xiao, Wei Wang, Chuan Qin, Daishi Tian
Chimeric antigen receptor (CAR)-T cell therapy has achieved remarkable success in the treatment of hematological malignancies. Based on the immunomodulatory capability of CAR-T cells, efforts have turned toward exploring their potential in treating autoimmune diseases. Bibliometric analysis of 210 records from 128 academic journals published by 372 institutions in 40 countries/regions indicates a growing number of publications on CAR-T therapy for autoimmune diseases, covering a range of subtypes such as systemic lupus erythematosus, multiple sclerosis, among others...
April 12, 2024: Chinese Medical Journal
https://read.qxmd.com/read/38611704/the-role-and-mechanism-of-paeoniae-radix-alba-in-tumor-therapy
#13
REVIEW
Yating Yang, Ling Yuan, Kaili Wang, Doudou Lu, Fandi Meng, Duojie Xu, Weiqiang Li, Yi Nan
Tumors have a huge impact on human life and are now the main cause of disease-related deaths. The main means of treatment are surgery and radiotherapy, but they are more damaging to the organism and have a poor postoperative prognosis. Therefore, we urgently need safe and effective drugs to treat tumors. In recent years, Chinese herbal medicines have been widely used in tumor therapy as complementary and alternative therapies. Medicinal and edible herbs are popular and have become a hot topic of research, which not only have excellent pharmacological effects and activities, but also have almost no side effects...
March 22, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38611082/transperineal-laser-ablation-tpla-treatment-of-focal-low-intermediate-risk-prostate-cancer
#14
JOURNAL ARTICLE
Gugliemo Manenti, Tommaso Perretta, Marco Nezzo, Federico Romeo Fraioli, Beatrice Carreri, Paola Elda Gigliotti, Andrea Micillo, Andrea Malizia, Daniele Di Giovanni, Colleen Patricia Ryan, Francesco Giuseppe Garaci
Background: This interventional pilot study aimed to evaluate the short-term (3 years) efficacy of focal laser ablation (FLA) in treating the index lesion of low-intermediate-risk prostate cancer, along with assessing the safety of the procedure (ClinicalTrials.gov ID NCT04045756). Methods: Forty patients aged between 46 and 86 with histologically proven organ-confined prostate cancer and low-to-intermediate progression risk were included. FLA was performed under percutaneous fusion magnetic resonance/ultrasound guidance in a Day Hospital setting under local anesthesia...
April 3, 2024: Cancers
https://read.qxmd.com/read/38610728/falcotentorial-meningiomas-insights-from-surgical-strategies-and-clinical-outcomes
#15
JOURNAL ARTICLE
Arthur H A Sales, Christine Steiert, Simon P Behringer, Marco Bissolo, Mazin Omer, Theresa Bettina Loidl, Jürgen Beck, Jürgen Grauvogel
Background : Falcotentorial meningiomas are exceptionally uncommon tumors, presenting a challenge for neurosurgeons due to their close proximity to vital structures. Gross total resection represents the standard of treatment for these tumors. However, care must be taken when surgically approaching these lesions, since damaging neurovascular structures may cause unacceptable morbidity. Selecting the optimal surgical approach for each tumor is of paramount importance when treating these patients. Methods : The authors reviewed medical records to identify all patients with falcotentorial meningiomas who underwent resection at the University Hospital of Freiburg between January 2001 and December 2021...
March 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38605087/synthetic-biology-approaches-for-improving-the-specificity-and-efficacy-of-cancer-immunotherapy
#16
REVIEW
Bo Zhu, Hang Yin, Di Zhang, Meiling Zhang, Xiaojuan Chao, Luca Scimeca, Ming-Ru Wu
Immunotherapy has shown robust efficacy in treating a broad spectrum of hematological and solid cancers. Despite the transformative impact of immunotherapy on cancer treatment, several outstanding challenges remain. These challenges include on-target off-tumor toxicity, systemic toxicity, and the complexity of achieving potent and sustainable therapeutic efficacy. Synthetic biology has emerged as a promising approach to overcome these obstacles, offering innovative tools for engineering living cells with customized functions...
April 11, 2024: Cellular & Molecular Immunology
https://read.qxmd.com/read/38604813/autologous-human-preclinical-modeling-of-melanoma-interpatient-clinical-responses-to-immunotherapeutics
#17
JOURNAL ARTICLE
Yee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, Claudia Marcela Diaz-Montero, Ye F Tian, Marc S Ernstoff, Pauline Funchain, Jennifer S Ko, Raymond Winquist, Heather C Losey, Jan Joseph Melenhorst, Brian R Gastman
BACKGROUND: Despite recent advances in immunotherapy, a substantial population of late-stage melanoma patients still fail to achieve sustained clinical benefit. Lack of translational preclinical models continues to be a major challenge in the field of immunotherapy; thus, more optimized translational models could strongly influence clinical trial development. To address this unmet need, we designed a preclinical model reflecting the heterogeneity in melanoma patients' clinical responses that can be used to evaluate novel immunotherapies and synergistic combinatorial treatment strategies...
April 11, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38602657/anatomical-assessment-of-local-recurrence-site-in-breast-cancer-patients-after-breast-reconstruction-and-post-mastectomy-radiotherapy-implications-for-radiation-volumes-and-techniques
#18
JOURNAL ARTICLE
Viola Salvestrini, Marianna Valzano, Icro Meattini, Carlotta Becherini, Luca Visani, Giulio Francolini, Ilaria Morelli, Niccolò Bertini, Lorenzo Orzalesi, Marco Bernini, Simonetta Bianchi, Gabriele Simontacchi, Lorenzo Livi, Isacco Desideri
INTRODUCTION: Post-mastectomy radiotherapy (PMRT) improves local control rates and survival in patients with adverse prognostic features. The dose coverage to target volumes is critical to yield maximum benefit to treated patients, increasing local control and reducing risk of toxicity. This study aims to assess patterns of breast cancer relapse in patients treated with mastectomy, breast reconstruction and PMRT. METHODS: Breast cancer patients treated with PMRT between 1992 and 2017 were retrospectively reviewed...
April 11, 2024: La Radiologia Medica
https://read.qxmd.com/read/38599804/-chinese-expert-consensus-on-refractory-lung-cancer
#19
JOURNAL ARTICLE
(no author information available yet)
The incidence and mortality of lung cancer in China are the highest of all malignant tumors, seriously endangering people's lives and health. Refractory lung cancer is lung cancer that is unresponsive to standard treatment and is difficult to treat, or lung cancer for which a standard treatment has not yet been defined. However, there is still a lack of clear definition and consensus on the treatment of refractory lung cancer. In order to provide guidance for the clinically effective and safe treatment of refractory lung cancer, experts from Chinese Thoracic Society Lung Cancer Study Group have formulated this consensus, on the basis of the actual situation in the field of diagnosis and treatment in our country, with reference to the latest research data, relevant guidelines at home and abroad and experts' clinical practice experience...
April 12, 2024: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/38595331/tumor-microenvironment-reprogramming-by-nanomedicine-to-enhance-the-effect-of-tumor-immunotherapy
#20
REVIEW
Yu Huang, Hui Fan, Huihui Ti
With the rapid development of the fields of tumor biology and immunology, tumor immunotherapy has been used in clinical practice and has demonstrated significant therapeutic potential, particularly for treating tumors that do not respond to standard treatment options. Despite its advances, immunotherapy still has limitations, such as poor clinical response rates and differences in individual patient responses, largely because tumor tissues have strong immunosuppressive microenvironments. Many tumors have a tumor microenvironment (TME) that is characterized by hypoxia, low pH, and substantial numbers of immunosuppressive cells, and these are the main factors limiting the efficacy of antitumor immunotherapy...
April 2024: Asian journal of pharmaceutical sciences
keyword
keyword
103816
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.